Literature DB >> 29358003

Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection.

Davide Stolfo1, Antonio De Luca2, Gaetano Morea2, Marco Merlo2, Giancarlo Vitrella2, Thomas Caiffa2, Giulia Barbati3, Serena Rakar2, Renata Korcova2, Andrea Perkan2, Bruno Pinamonti2, Aniello Pappalardo4, Alessandra Berardini5, Elena Biagini5, Francesco Saia5, Francesco Grigioni5, Claudio Rapezzi5, Gianfranco Sinagra2.   

Abstract

BACKGROUND: Patients with heart failure (HF) and severe symptomatic functional mitral regurgitation (FMR) may benefit from MitraClip implantation. With increasing numbers of patients being treated the success of procedure becomes a key issue. We sought to investigate the pre-procedural predictors of device failure in patients with advanced HF treated with MitraClip.
METHODS: From April 2012 to November 2016, 76 patients with poor functional class (NYHA class III-IV) and severe left ventricular (LV) remodeling underwent MitraClip implantation at University Hospitals of Trieste and Bologna (Italy). Device failure was assessed according to MVARC criteria. Patients were subsequently followed to additionally assess the patient success after 12months.
RESULTS: Mean age was 67±12years, the mean Log-EuroSCORE was 23.4±16.5%, and the mean LV end-diastolic volume index and ejection fraction (EF) were 112±33ml/m2 and 30.6±8.9%, respectively. At short-term evaluation, device failure was observed in 22 (29%) patients. Univariate predictors of device failure were LVEF, LV and left atrial volumes and anteroposterior mitral annulus diameter. Annulus dimension (OR 1.153, 95% CI 1.002-1.327, p=0.043) and LV end-diastolic volume (OR 1.024, 95% CI 1.000-1.049, p=0.049) were the only variables independently associated with the risk of device failure at the multivariate model.
CONCLUSIONS: Pre-procedural anteroposterior mitral annulus diameter accurately predicted the risk of device failure after MitraClip in the setting of advanced HF. Its assessment might aid the selection of the best candidates to percutaneous correction of FMR.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heart failure; MitraClip; Mitral annulus; Mitral regurgitation

Mesh:

Year:  2018        PMID: 29358003     DOI: 10.1016/j.ijcard.2018.01.009

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  [Cardioband®: Where do we stand, who are suitable patients?]

Authors:  C Frerker; T Schmidt; R Pfister; M I Körber; V Mauri; M Wösten; S Baldus
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

2.  Mitral valve leaflet repair with the new PASCAL system: early real-world data from a German multicentre experience.

Authors:  Steffen D Kriechbaum; Niklas F Boeder; Luise Gaede; Martin Arnold; Ursula Vigelius-Rauch; Peter Roth; Michael Sander; Andreas Böning; Matthias Bayer; Albrecht Elsässer; Helge Möllmann; Christian W Hamm; Holger M Nef
Journal:  Clin Res Cardiol       Date:  2019-08-26       Impact factor: 5.460

Review 3.  Treatment of Functional Mitral Regurgitation in Heart Failure.

Authors:  Enrico Fabris; Antonio De Luca; Giancarlo Vitrella; Davide Stolfo; Marco Masè; Renata Korcova; Marco Merlo; Serena Rakar; Arnoud W J Van't Hof; Elvin Kedhi; Andrea Perkan; Gianfranco Sinagra
Journal:  Curr Cardiol Rep       Date:  2019-11-16       Impact factor: 2.931

4.  Left ventricular geometry predicts optimal response to percutaneous mitral repair via MitraClip: Integrated assessment by two- and three-dimensional echocardiography.

Authors:  Jiwon Kim; Javid Alakbarli; Maria Chiara Palumbo; Lola X Xie; Lisa Q Rong; Nathan H Tehrani; Lillian R Brouwer; Richard B Devereux; Shing Chiu Wong; Geoffrey W Bergman; Omar K Khalique; Robert A Levine; Mark B Ratcliffe; Jonathan W Weinsaft
Journal:  Catheter Cardiovasc Interv       Date:  2019-02-21       Impact factor: 2.692

5.  Relation of Mitral Annulus and Left Atrial Dysfunction to the Severity of Functional Mitral Regurgitation in Patients with Dilated Cardiomyopathy.

Authors:  Sorina Mihaila Baldea; Denisa Muraru; Marcelo Haertel Miglioranza; Sabino Iliceto; Dragos Vinereanu; Luigi Paolo Badano
Journal:  Cardiol Res Pract       Date:  2020-07-09       Impact factor: 1.866

6.  Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Thomas Sommer; Niklas Boeder; Matthias Bayer; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

Review 7.  Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle.

Authors:  Aldostefano Porcari; Antonio De Luca; Chrysanthos Grigoratos; Federico Biondi; Giorgio Faganello; Giancarlo Vitrella; Gaetano Nucifora; Giovanni Donato Aquaro; Marco Merlo; Gianfranco Sinagra
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

8.  Predictors of functional mitral regurgitation recurrence after percutaneous mitral valve repair.

Authors:  Katharina Hellhammer; Jean M Haurand; Maximilian Spieker; Peter Luedike; Tienush Rassaf; Tobias Zeus; Malte Kelm; Ralf Westenfeld; Patrick Horn
Journal:  Heart Vessels       Date:  2021-04-03       Impact factor: 2.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.